基于碳的纳米技术用于帕金森病:诊断和治疗创新
Zainab Lafi1,2, Sherine Asha3, Sara Yousef Asha3
1Department of pharmaceutics and pharmaceutical technology, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan.
Nanomedicine (London, England)
|July 23, 2025
概括
碳基纳米材料在帕金森病 (PD) 诊断和治疗方面表现有前途. 这些材料提供神经保护,通过血脑屏障提供向药物,并为PD提供早期生物标志物检测.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 神经科学是一个神经科学.
背景情况:
- 神经退行性疾病涉及渐进的神经元损失.
- 帕金森病 (PD) 的特点是多巴胺能神经元退化和α-synuclein聚合.
- 目前的PD诊断和治疗方法有局限性,需要新的方法.
研究的目的:
- 审查碳基纳米材料 (CBNPs) 在解决帕金森病挑战中的应用.
- 突出CBNP作为神经保护剂,药物输送系统和PD诊断工具的潜力.
- 讨论PD中CBNP的治疗潜力和未来研究方向.
主要方法:
- 关于碳基纳米材料 (石墨烯,CNT,富勒伦) 和它们在帕金森病中的应用现有文献的综述.
- 对CBNP与神经保护,药物输送和生物感知相关的特性进行分析.
- 检查CBNP对PD的治疗应用的最新进展.
主要成果:
- CBNP 显示出作为抗氧化应激神经保护剂的潜力.
- CBNP可以作为有效的药物递送系统,能够穿越血脑屏障.
- CBNP 作为高度敏感的生物传感器,用于早期检测PD生物标志物.
- 新出现的证据表明,CBNP可以在PD管理中充当治疗神经障碍的药物.
结论:
- 碳基纳米材料为改善帕金森病的早期诊断和向治疗提供了显著的潜力.
- 进一步的研究对于解决CBNP在PD临床转化中的安全性,生物相容性和可扩展性问题至关重要.
- 在像PD这样的神经退行性疾病中,CBNP代表了创新的治疗和诊断策略的有希望的前沿.
相关概念视频
Parkinson's Disease: Treatment
381
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
381
Parkinson's Disease: Overview
713
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
713
Neural Regulation
40.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.1K


